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Abstract
Background: We aimed to investigate the immediate respiratory effects of cigar smoking(CS), among young
smokers with and without mild asthma.
Materials and methods: Forty-seven young smokers (18–31years old, 29 males, average pack-years = 3.6 ± 2.8)
were enrolled. Twenty-two were mild asthmatics(MA-subgroup) and the remaining 25 were otherwise healthy
smokers(HS-subgroup). Exhaled carbon monoxide(eCO), multi-frequency respiratory system impedance(Z),
resistance(R), reactance(X), frequency-dependence of resistance(fdr = R5Hz - R20Hz), resonant frequency(fres),
reactance area(AX) and exhaled nitric oxide(FENO) were measured at the aforementioned sequence, before and
immediately after 30 min of CS, or equal session in the smoking area while using a sham cigar(control group).
Chi-square, student’s t-tests, mixed linear models and Pearson correlation tests were used for the statistical analysis;
level of significance was defined as p < 0.05.
Results: Immediately after CS, Z5Hz, R5Hz, R10Hz, R20Hz and eCO increased significantly in both subgroups(MA
and HS). A greater increase was found for R20 in HS-subgroup. Fdr, fres and AX increased in MA, while decreased in
HS. On the contrary, X10 decreased in MA and increased in HS, while X20 showed a greater decrease in MA.
Changes in fdr, fres and AX were significantly correlated in both subgroups. No significant FENO alterations were
detected in both subgroups.
Conclusion: CS has immediate effects on pulmonary function. Mild asthma predisposes to higher increase of
peripheral resistance(increased fdr). In otherwise healthy smokers, central resistance(R20Hz) is more affected. FENO
levels are not significantly affected by CS.
Abbreviations: AX, Reactance area; CO, Carbon monoxide; COHb%, Carboxyhemoglobin %; C, Control group;
CS, Cigar smoking; eCO, Exhaled carbon monoxide; fdr, Frequency dependence of resistance; FEF25%, Expiratory flow
at 25 % of exhaled forced vital capacity; FEF50%, Expiratory flow at 50 % of exhaled forced vital capacity;
FEF75%, Expiratory flow at 75 % of exhaled forced vital capacity; FEF25–75%, Expiratory flow at 25 to 75 % of exhaled
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forced vital capacity; FENO, Fractional exhaled nitric oxide; FEV1, Forced expiratory volume at 1 second;
fres, Resonant frequency; FVC, Forced vital capacity; IOS, Impulse oscillometry system; HS, Healthy smokers; MA, Mild
asthma; PEF, Peak expiratory flow; PM10, Particulate number 1.0; ppb, Parts per billion; ppm, Parts per million;
R5, Respiratory system resistance at 5 Hz; R10, Respiratory system resistance at 10 Hz; R20, Respiratory system
resistance at 20 Hz; X5, Respiratory system reactance at 5 Hz; X10, Respiratory system reactance at 10 Hz;
X20, Respiratory system reactance at 20 Hz; Z5, Respiratory system total impedance at 5 Hz
Background
Immediate respiratory effects of cigarette, e-cigarette
and water-pipe smoking have been adequately investi-
gated [1–4]. For cigar smoking(CS), however, there is
relative lack of such studies. Recent data regarding
long-term effects of CS on pulmonary function, detect
that CS is associated with decreased values of FEV1
and FEV1/FVC, and increased odds of airflow ob-
struction, even in subjects who have never smoked
cigarettes [5]. Therefore, we hypothesized that there
are also immediate respiratory effects, even after a
single cigar smoking.
Furthermore, smoking population includes people
with respiratory co-morbidities. Asthma is the most
prevalent of them among young smokers and it has
been shown that approximately 30 % of adults with
asthma are current smokers [6]. Cigarette smoking is
known to be responsible for accelerated decline in lung
function among asthmatics [7] and poorer control of
asthma symptoms [8]. Furthermore, cigarette smoking
has been proved to have more deleterious immediate
inflammatory effects in asthmatic smokers compared to
healthy smokers [9]. Based on the above, we found in-
teresting to test the hypothesis that the acute respira-
tory system response to CS would be different among
otherwise healthy smokers and smokers with mild
asthma, considering also that CS is a more intense
stimuli than cigarette smoking [10].
Our experimental design was focused on young
smokers because CS is popular amongst the youth, with
a reported prevalence of 12.6 % among high school stu-
dents in the USA [11]. Moreover, young smokers are
more vulnerable to unrealistic perceptions regarding
safety of CS, used as advertisement tools from tobacco
industry. It has been shown that only 8.7 % of cigar
smokers consider themselves to be at high risk of cancer
development, while the glamorized image of cigar smokers
presented in the media appears to be accepted both by
those who smoke cigars and those who do not [10].
Through this study, we aimed to detect the immediate
respiratory effects of CS and, particularly, to investigate
the possibility of a different acute response of the




Forty-seven young adults (29 males, average age = 23.4 ±
4.2 y, range = 18–31y) voluntarily participated in the
study. Twenty-two of them were mild asthmatics, being
recruited from our outpatients’ lung function clinic(MA-
subgroup). All twenty-two asthmatics were sporadically
treated with short-acting β2-agonists. They all reported
atopic history (20 with allergic rhinitis, five with allergic
conjunctivitis and two with atopic dermatitis), mild dry
cough, chest tightness and wheezing. All symptoms were
sporadic, elicited by exposure to certain substances, or
following respiratory infections. All 22 MA-subjects
completed the Asthma Control Questionnaire(ACT) and
reported an ACT-score ≥20. Furthermore, they were all
free of symptoms and any medication at the time of the
study (conducted out of pollen season), and for the past
4 weeks. The remaining 25 subjects were otherwise
healthy smokers(HS-subgroup).
All 47 subjects were current cigarette smokers (re-
ported smoking of at least one cigarette during the past
30 days [12–14], average cigarette consumption was 3.6
pack-years) and frequent cigar smokers (approximate
consumption = 1 cigar/week). Exclusion criteria for all
subjects included any kind of diseases (even a common
cold during the previous 2 weeks) with the exception of
mild asthma in MA-subgroup, pregnancy, lactation and
current use of any medication.
Study design
A crossover, laboratory-based study design was applied on
the abovementioned subpopulations, in experimental and
control sessions, which the participants underwent one at
a time. During experimental session, each of the 47 sub-
jects was instructed to remain in sitting position and
smoke a single cigar ad lib for 30 min inside a special
smoking area (3.6 m × 3 m× 2.7 m = 29.16 m3) with the
door closed and the window opened. Each participant
smoked approximately half of a large cigar (9 g weight,
150 mm length, 13 mm diameter)1. For control purposes,
each of the 47 subjects used a sham cigar of the same size
ad lib for 30 min, under the above mentioned conditions.
Since there was no smoke production by the use of the
sham cigar, blind control was impossible.
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In line with relevant, previously published methodology,
all 47 subjects were instructed to avoid consuming food,
drinks, beverages 4 h prior to each session [1–4]. In regard
to the time of smoking abstinence prior to the measure-
ments, there is considerable inconsistency in the literature,
ranging from hours to days [15–17]. Furthermore, the
time frame for detecting the short-term effects of CS on
lung function is unclear. We chose abstinence from both
cigarette and cigar smoking for 12 h prior to the measure-
ments, which has been previously used in studies with
relevant objectives and methodology [9]. Furthermore,
this time frame secured the good compliance of the sub-
jects to abstinence from smoking. Each session began at
8 am and each participant was advised to avoid smoking
between 8 pm and 8 am. This setting was easily achievable
by all our subjects, who were mild smokers.
The ethics committee of the Hellenic Cancer Society,
Athens, Greece, provided ethics approval (protocol num-
ber: 561/28-1-14). Each subject read and signed an
informed consent form prior to study enrollment.
Pulmonary function assessment
Spirometry was performed at an initial session (day 1),
along with the assessment of the subjects’ medical his-
tory (including ACT in the MA-subgroup). In the sec-
ond (control) and the third (experimental) session,
measurement of the exhaled carbon monoxide(eCO),
impulse oscillometry(IOS) and measurement of frac-
tional exhaled nitric oxide(FENO) were performed in the
above mentioned sequence, before and immediately after
the corresponding intervention. All three sessions took
place in three consecutive days and the control session
(day 2) always preceded the experimental session (day 3)
for consistency purposes.
(i) Spirometry and flow-volume loop
Dynamic expiratory lung volumes and flows (FVC,
FEV1, FEV1/FVC %, PEF, and FEF at 25, 50, and
75 % of exhaled VC) were measured in sitting
position with a nose-clip applied, using a Jaeger
MasterScreen spirometry system in all subjects
according to the recommendations of the ATS/ERS
task force guidelines [18]. Predicted values of the
abovementioned parameters were calculated by the
software of the equipment used.
(i) eCO measurements
Measurements were performed with the Bedfont
“Microsmokerlyser” equipment, according to the
operating instructions provided by the
manufacturer: a nose-clip was applied on the
subjects, and they were instructed to quietly inhale
and hold their breath for approximately 15 s, and
consecutively quietly exhale for approximately 10 s.
(ii) IOS measurements
Respiratory system total impedance at 5 Hz(Z5),
resistance at 5, 10, and 20 Hz (R5, R10, and R20),
frequency dependence of resistance(fdr = R5-R20),
reactance at 5, 10, and 20 Hz (X5, X10, and X20),
resonant frequency(fres) and reactance area(AX)
were measured with the use of the Viasys Jaeger
Masterscreen IOS system (heated pneumotach,
resistance = 0.05 kPa/(L/s) at 10 L/s), according to
the ERS task force guidelines [19]. Three
reproducible consecutive trials (CV% < 10 %) were
performed, of 90 s duration each.
(iii)FENO measurements
Measurements were made in sitting position with a
nose-clip applied, using an Eco Medics AG CLD 88
Series chemiluminescence analyzer equipped with a
Spiroware 3.0 software program. Subjects were
instructed to inhale deeply through a filtered
mouthpiece and consecutively exhale at a mouth
flow rate of approximately 50 mL/s for 10 s.
Expiratory flow was held approximately steady by
applying a constant positive pressure(10 cmH2O)
through a resistance factor, while instructing the
patient to exhale steadily using visual stimulation on
the system screen. Three reproducible consecutive
trials(CV% < 10 %) were performed with a 30 s.
interval.
Statistical analysis
Quantitative variables were expressed as mean values
(SD), while qualitative variables were expressed as abso-
lute and relative frequencies. For the comparison of pro-
portions chi-square tests were used. Student’s t-tests
were used for the comparison of spirometric data, base-
line impulse oscillometry(IOS) and fractional exhaled ni-
tric oxide(FENO) measurements between young subjects
with mild asthma(MA) and healthy smokers(HS). Pear-
son correlation coefficients were computed in order to
explore the association of changes in IOS measurements
after cigar smoking.
In order to evaluate the effect of smoking, the ef-
fect of mild asthma, and the interaction effect of time
(pre vs. post measurements) with smoking (cigar
smoking or control session) mixed linear models were
used [20, 21]. In order to investigate if changes before
and after the smoking session were different between
the group with mild asthma (MA) and the group of
healthy smokers (HS), the interaction effect of time
with the presence of asthma was tested in mixed lin-
ear models that referred only to smoking session. Re-
gression coefficients (β) with standard errors (SE)
were computed from the results of the models.
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In each of the mixed linear models, each outcome of
impulse oscillometry(IOS), fractional exhaled nitric oxi-
de(FENO) and exhaled carbon monoxide(eCO) mea-
surements represented a single dependent variable, and
it was tested simultaneously for the effect of time,
asthma and smoking, along with the interaction effects.
All reported p values are two-tailed. Statistical signifi-
cance was set at p < 0.05 and analyses were conducted
using STATA statistical software(version 11.0).
Results
Demographics and baseline spirometric data are presented
in Table 1. MA and HS subgroups were similar in terms
of sex, age, BMI and pack-years index(Table 1). Asthmatic
smokers presented with significantly lower values of FEV1,
FEV1/FVC, FEF25%-75%, FEF25%, FEF50% and FEF75% com-
pared with healthy smokers. Baseline IOS, FENO and
eCO measurements are presented in Table 2. Significantly
higher baseline values of Z5, R5, R10, R20, X5 and FENO
were found in asthmatics in both experimental and con-
trol sessions. fres, X10 and AX differed between MA and
HS subgroup at baseline measurements of control session.
Table 3 shows mean changes of IOS, FENO and eCO
measurements before and immediately after 30 min of
cigar smoking or control session separately in MA and
HS subgroups.
Results from mixed linear models for IOS, FENO and
eCO measurements are shown in Table 4. Significant
changes from pre and post CS measurements were
found for Z5, R5, R10, R20 and eCO. Also, a significant
interaction effect of smoking with time was found for
the aforementioned parameters, indicating that Z5, R5,
Table 1 Demographics and baseline spirometric data for young
smokers with mild asthma (MA subgroup) and healthy young
smokers (HS subgroup)
MA subgroup HS subgroup
(N = 22) (N = 25)
Mean (SD) Mean (SD) P
Sex, N (%)
Males 12 (54.5) 17 (68.0) 0.344*
Females 10 (45.5) 8 (32.0)
Age (years) 23.6 (3.9) 23.2 (4.5) 0.525**
BMI (kg/cm2) 23.9 (2.9) 23 (3.4) 0.404**
Pack-years 3.6 (2.6) 3.6 (2.9) 0.747**
FVC (% pred.) 97.75 (10.6) 105.5 (10.8) 0.013**
FEV1 (% pred.) 90.58 (9.4) 109.5 (9.2) <0.001**
FEV1/FVC (% pred.) 79 (5.6) 88.8 (5.3) <0.001**
PEF (% pred.) 91.49 (12.3) 99 (13.1) 0.062**
FEF25%-75% (% pred.) 71.44 (13.9) 112.7 (22.3) <0.001**
FEF25% (% pred.) 85.8 (16.6) 111 (16.6) <0.001**
FEF50% (% pred.) 76.46 (14.6) 114 (19.9) <0.001**
FEF75% (% pred.) 68.63 (20.0) 118 (39.6) <0.001**
*Pearson’s chi-square test; **Student’s t-test
Table 2 Baseline impulse oscillometry (IOS), fractional exhaled
nitric oxide (FENO) and exhaled carbon monoxide (eCO)
measurements in young subjects with mild asthma (MA) and
healthy smokers (HS), in experimental (smoking) and control
sessions separately
MA (N = 22) HS (N = 25)
Mean (SD) Mean (SD) P*
Z5 [kPa/(L/s)]
Exrerimental group 0.41 (0.13) 0.30 (0.06) <0.001
Control group 0.42 (0.13) 0.31 (0.07) 0.001
R5 [kPa/(L/s)]
Exrerimental group 0.39 (0.12) 0.28 (0.06) <0.001
Control group 0.40 (0.13) 0.29 (0.07) 0.001
R10 [kPa/(L/s)]
Exrerimental group 0.36 (0.11) 0.26 (0.05) <0.001
Control group 0.33 (0.11) 0.27 (0.07) 0.001
R20 [kPa/(L/s)]
Exrerimental group 0.35 (0.10) 0.26 (0.05) <0.001
Control group 0.36 (0.10) 0.27 (0.08) 0.002
fdr [kPa/(L/s)]
Exrerimental group 0.04 (0.06) 0.03 (0.03) 0.407
Control group 0.04 (0.06) 0.02 (0.04) 0.102
fres (Hz)
Exrerimental group 11.84 (3.35) 10.48 (2.75) 0.133
Control group 12.83 (4.73) 10.31 (2.43) 0.024
X5 [kPa/(L/s)]
Exrerimental group −0.12 (0.05) −0.09 (0.03) 0.014
Control group −0.13 (0.05) −0.10 (0.03) 0.015
X10 [kPa/(L/s)]
Exrerimental group −0.02 (0.05) 0.0004 (0.03) 0.070
Control group −0.02 (0.05) 0.004 (0.03) 0.026
X20 [kPa/(L/s)]
Exrerimental group 0.08 (0.05) 0.09 (0.05) 0.325
Control group 0.09 (0.08) 0.10 (0.05) 0.643
AX (kPa/L)
Exrerimental group 0.42 (0.48) 0.23 (0.17) 0.072
Control group 0.47 (0.49) 0.23 (0.15) 0.029
FENO (ppb)
Exrerimental group 22.50(15.6) 12.00 (6.9) 0.004
Control group 19.84 (14.6) 10.57 (4.7) 0.004
eCO (ppm)
Exrerimental group 3.68 (2.01) 4.40 (2.31) 0.265
Control group 4.14 (2.12) 3.84 (2.27) 0.647
*Student’s t-test
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R10, R20 and eCO increased significantly in both healthy
and asthmatics but only after smoking and not in con-
trol session.
eCO raised dramatically after smoking(up to 352.7 %)
in both subgroups. Z5 increased by 8.8 % in HS and
10.6 % in MA. R5 raised by 10.4 % in HS and 11.5 % in
MA. R10 raised by 12 % in HS and 8.3 % in MA. R20 in-
creased by 16.6 % in HS and 4.8 % in MA. For all the
aforementioned parameters, no significant differences in
the degree of change was found between healthy and
asthmatic smokers.
Table 5 presents the results from mixed linear models
for significant findings concerning the differences in the
degree of changes before and after smoking between
healthy and asthmatics. A significant interaction of mild
asthma with time was found for R20, fdr, fres, X10, X20
and AX. A greater increase was found for R20 in HS
(+16.6 %) compared with MA (+4.8 %), p = 0.017. Fdr in-
creased by 72.1 % in MA and decreased by 50 % in HS
(p < 0.001). Fres increased by 13.1 % in MA and de-
creased by 2.6 % in HS (p = 0.007). Also, AX raised by
35.4 % in MA, whereas showed a decrease by 6 % in HS
(p = 0.012). The aforementioned differences are illus-
trated in Fig. 1a, b and c.
X10 decreased in MA by 76.6 % and increased in HS
subgroup by 1200 % (p = 0.001), while X20 showed a
greater decrease in MA(−24.7 %) compared to HS(−1.3 %),
p = 0.007 (Fig. 1d).
Changes in AX, fdr and fres were significantly corre-
lated in both MA and HS subgroups (p < 0.05) indicating
that greater changes in one parameter are associated
with greater changes in other IOS measurements.
FENO was not changed significantly after smoking,
and no difference in the degree of FENO change was
found between healthy and asthmatic smokers.
Discussion
In this crossover study, we investigated for first time the
immediate effects of CS on respiratory mechanics and
exhaled biomarkers, among young regular cigarette and
frequent cigar smokers with and without mild asthma.
In order to investigate the effect of asthma on the acute
respiratory system response to CS, we chose to include
young smokers with mild, well controlled asthma
(ACT ≥ 20), who had never been treated systematically,
so as to avoid the influence of treatment and thereby in-
vestigate the naïve airway response to CS. Furthermore,
this design allowed us to compare the lung function out-
comes between asthmatics and healthy subjects in order
to identify the true asthma effect, since there was no al-
teration to the bronchomotor tone and reflexes caused
by long-term treatment with bronchodilators and anti-
inflammatory medication.
Table 3 Mean changes of impulse oscillometry (IOS), fractional
exhaled nitric oxide (FENO) and exhaled carbon monoxide
(eCO) measurements before and immediately after 30 min of
cigar smoking (experimental session) or control session
separately in young smokers with mild asthma (MA) and
healthy smokers (HS)
MA (n = 22) HS (n = 25)
Change (%) Change (%)
Z5 [kPa/(L/s)]
Exrerimental group +0.04 (+10.6 %) +0.03 (+8.8 %)
Control group −0.02 (−4.0 %) −0.01 (−2.6 %)
R5 [kPa/(L/s)]
Exrerimental group +0.05 (+11.5 %) +0.03 (+10.4 %)
Control group −0.02 (−4.1 %) −0.01 (−2.7 %)
R10 [kPa/(L/s)]
Exrerimental group +0.03 (+8.3 %) +0.03 (+12.0 %)
Control group −0.02 (−5.1 %) −0.01 (−2.3 %)
R20 [kPa/(L/s)]
Exrerimental group +0.02 (+4.8 %) +0.04 (+16.6 %)
Control group −0.01 (−3.8 %) −0.003 (−1.0 %)
fdr [kPa/(L/s)]
Exrerimental group +0.03 (+72.1 %) −0.01 (−50.0 %)
Control group −0.003 (−6.5 %) −0.01 (−26.5 %)
fres (Hz)
Exrerimental group +1.55 (+13.1 %) −0.27 (−2.6 %)
Control group +0.17 (+1.3 %) −0.03 (−0.3 %)
X5 [kPa/(L/s)]
Exrerimental group −0.04 (+3.4 %) +0.003 (−3.4 %)
Control group +0.002 (−1.8 %) −0.002 (+1.7 %)
X10 [kPa/(L/s)]
Exrerimental group −0.02 (+76.6 %) +0.005 (+1200 %)
Control group −0.003 (+13.5 %) 0,00 (0,0 %)
X20 [kPa/(L/s)]
Exrerimental group −0.02 (−24.7 %) −0.001 (−1.3 %)
Control group −0.02 (−20.9 %) −0.004 (−4.06 %)
AX (kPa/L)
Exrerimental group +0.15 (+35.4 %) −0.013 (−6.0 %)
Control group +0.04 (+7.5 %) −0.003 (−1.2 %)
FENO (ppb)
Exrerimental group −2.41 (−10.7 %) −0.52 (−4.4 %)
Control group +0.38 (+1.9) +0.35 (+3.4 %)
eCO (ppm)
Exrerimental group +11.36 (308.6 %) +15.52 (+352.7 %)
Control group +0.18 (+4.4 %) +0.16 (+4.2 %)
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We found that, immediately after 30 min of CS, levels
of eCO increased dramatically (up to 352.7 %) and, as
expected, no difference was detected between healthy
and asthmatics. According to the calculations provided
by the equipment used, the observed changes of eCO
corresponded to a significant average increase of carb-
oxyhemoglobin (COHb%), equal in both subgroups.
Those findings are compatible with results of other stud-
ies investigating the chronic effect of CS on eCO and
COHb [22–24] and they confirm that CS is not safe in
terms of CO pollution.
In regard to pulmonary function assessment, we
avoided pre vs. post CS comparison of spirometric mea-
surements, since it has been shown that the forced ma-
neuvers required may alter the bronchomotor tone [25],
influencing IOS [26, 27] and FENO measurements [28].
Furthermore, IOS has been proved more sensitive than
spirometry, since changes in IOS-resistance precede
changes in PEF and FEV1 in experimentally induced air-
way obstruction [29].
According to our findings, CS caused significant increase
of respiratory system total impedance(Z5) in both healthy
and asthmatics. This change was attributable to the signifi-
cant increase of total resistance(R5), since low frequency
reactance(X5) values, reflecting respiratory system elas-
tance, were not significantly modified. Furthermore, cen-
tral airways resistance(R20) increased significantly in both
subgroups, which was possibly attributable to the consid-
erable concentrations of thoracic dust (PM10) but also
inhalable dust (particles diameter ≥1 μm) in cigar smoke
[30], normally wiped away by mucociliary clearance in lar-
ger airways, before reaching small airways or alveolar
space [31, 32]. Frequency dependence of resistance(fdr =
R5-R20), which is the most specific indicator of peripheral
Table 4 Regression coefficients (β) and standard errors (SE) from mixed linear models for impulse oscillometry (IOS), fractional
exhaled nitric oxide (FENO) and exhaled carbon monoxide (eCO) measurements, before and immediately after cigar smoking in
healthy and mild asthmatic young smokers
β for time (SE) P β for mild asthma (SE) P β for smoking (SE) P β for interaction of smoking
with time (SE)
P
Z5 [kPa/(L/s)] 0.08 (0.04) 0.025 0.11 (0.02) <0.001 0.01 (0.02) 0.703 −0.05 (0.02) 0.041
R5 [kPa/(L/s)] 0.09 (0.03) 0.012 0.11 (0.02) <0.001 0.01 (0.02) 0.686 −0.05 (0.02) 0.024
R10 [kPa/(L/s)] 0.07 (0.03) 0.013 0.10 (0.02) <0.001 0.01 (0.02) 0.536 −0.04 (0.02) 0.023
R20 [kPa/(L/s)] 0.07 (0.03) 0.019 0.08 (0.02) <0.001 0.01 (0.01) 0.497 −0.04 (0.02) 0.038
fdr [kPa/(L/s)] 0.02 (0.02) 0.387 0.03 (0.01) 0.006 −0.003 (0.01) 0.737 −0.01 (0.01) 0.391
fres (Hz) 1.10 (1.31) 0.400 2.46 (0.76) 0.001 0.37 (0.58) 0.523 −0.52 (0.83) 0.530
X5 [kPa/(L/s)] −0.001 (0.01) 0.966 −0.03 (0.01) 0.001 −0.004 (0.01) 0.525 0.0004 (0.01) 0.964
X10 [kPa/(L/s)] −0.01 (0.02) 0.575 −0.03 (0.01) 0.001 0.001 (0.01) 0.927 0.004 (0.01) 0.713
X20 [kPa/(L/s)] −0.01 (0.02) 0.670 −0.02 (0.01) 0.062 0.01 (0.01) 0.534 −0.001 (0.01) 0.950
AX (kPa/L) 0.11 (0.15) 0.460 0.27 (0.10) 0.005 0.02 (0.07) 0.719 −0.05 (0.10) 0.614
FENO (ppb) −3.18 (4.03) 0.431 9.47 (2.42) <0.001 −2.06 (1.80) 0.253 1.77 (2.55) 0.488
eCO (ppm) 27.0 (2.36) <0.001 −1.21 (2.72) 0.093 −0.09 (1.01) 0.933 −13.4 (1.43) <0.001
Significant changes from pre and post cigar smoking measurements were found for Z5, R5, R10, R20 and eCO. Also, a significant interaction effect of smoking
with time was found for the aforementioned parameters, indicating that Z5, R5, R10, R20 and eCO increased significantly in both healthy and asthmatics, but only
after smoking and not in control session
Table 5 Regression coefficients (β) and standard errors (SE) from mixed linear models for significant findings concerning the
differences in the degree of changes before and after cigar smoking between subjects with mild asthma (MA subgroup) and
otherwise healthy smokers (HS subgroup)
β for time (SE) P β for mild asthma (SE) P β for interaction of mild asthma
with time (SE)
P
R20 [kPa/(L/s)] 0.04 (0.01) <0.001 0.10 (0.02) <0.001 −0.03 (0.01) 0.017
fdr [kPa/(L/s)] −0.01 (0.004) 0.004 0.01 (0.02) 0.520 0.04 (0.01) <0.001
fres (Hz) −0.27 (0.47) 0.556 1.21 (1.06) 0.252 1.83 (0.68) 0.007
X10 [kPa/(L/s)] 0.01 (0.004) 0.252 −0.02 (0.01) 0.173 −0.02 (0.01) 0.001
X20 [kPa/(L/s)] −0.001 (0.01) 0.822 −0.01 (0.01) 0.583 −0.02 (0.01) 0.007
AX (kPa/L) −0.01 (0.04) 0.767 0.19 (0.14) 0.184 0.16 (0.07) 0.012
A significant interaction of mild asthma with time was found for R20, fdr, fres, X10, X20 and AX. A greater increase after smoking session was found for R20 in
healthy individuals. Fdr, fres and AX increased in asthmatics, while showed a decrease in healthy smokers. X10 decreased in asthmatics and increased in healthy
smokers, while X20 had a greater decrease in asthmatics
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resistance [33, 34], increased significantly in MA subgroup
(+72.1 %), whereas it decreased significantly in HS-
subgroup (−50 %), and the difference among the changes
was highly significant (p < 0.001, Fig. 1a). This indicates
that CS affected primarily the peripheral airways in asth-
matics, whereas in healthy subjects, dysfunction was lo-
cated primarily in central airways.
In particular, CS caused significantly higher increase of
R20 leading to a significant decrease of fdr in healthy
subjects (Table 5, Fig. 1a). The abovementioned pattern
has also been reported by Skloot et al. [35], who applied
IOS on nonsmokers ironworkers of the Trade Disaster
Centre, New York, presenting central airways dysfunc-
tion. At the same study [35], smoking population dem-
onstrated the pattern identified in our asthmatics, i.e.
higher increase of R5 and increased fdr, which is typical
of peripheral airways obstruction, detected in numerous
studies applying forced oscillometry on patients with
COPD [36–38].
We also found a significant increase of fres and AX and
decreased X10 and X20 in asthmatics, but not in healthy
smokers. The aforementioned changes are also indicative
of acute peripheral airways obstruction [36–38]. In par-
ticular, increased fdr, fres, and AX, have been proposed as
markers of airway closure and express the increased
“effective elastance” of the respiratory system [39],
but also ventilation inhomogeneity due to peripheral
bronchoconstriction [39, 40]. These strongly corre-
lated changes presumably represent the immediate ex-
pression of the additive effects of asthma and CS on
small airways function.
We also examined the immediate respiratory response
to CS in terms of FENO levels for first time. It is known
that FENO is immediately reduced after a single cigarette
smoking [1, 41], as well as after exposure to sidestream
secondhand cigarette smoking [42]. It has been proposed
that inhalation of cigarette smoke can acutely reduce
FENO through down-regulation of both endothelial and
Fig. 1 a Linear prediction of fdr before and after smoking session in the MA and HS group. b Linear prediction of fres before and after smoking
session in the MA and HS group. c Linear prediction of AX before and after smoking session in the MA and HS group. d Linear prediction of X20
before and after smoking session in the MA and HS group. MA =Mild Asthma, HS = Healthy Smokers
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inducible NO synthases [43–45], but also through the
rapid conversion of NO to peroxynitrite by reactive oxy-
gen and nitrogen species [44]. We hypothesized that since
cigar smoke is rich in nitrogen oxides [10], the above
mechanisms could be possibly leading to an acute FENO
reduction after CS. However, no significant change of
FENO was found, indicating that NO production was not
significantly affected by acute inhalation of cigar smoke.
Furthermore, the hypothesis of a different acute re-
sponse to CS between healthy and asthmatic smokers
was also not confirmed in terms of NO production,
since there was no difference in FENO changes between
MA and HS. In a recent study by Papaioannou et al. [9],
the same hypothesis was tested for cigarette smoking.
The authors recruited young smokers with and without
moderate, well controlled asthma, being treated with
long acting β2-agonists and inhaled corticosteroids, and
similar results were demonstrated, i.e. no significant
FENO alterations in both populations.
Based on the above, it seems that there is no differ-
ence regarding the acute respiratory system response
to tobacco smoke among healthy and asthmatic
smokers, in terms of NO production. Of course, fur-
ther evaluation of the abovementioned statement is
needed through large scale studies.
Our study has several limitations. Firstly, a small num-
ber of subjects was examined. Secondly, we didn’t inves-
tigate the time duration of the identified effects. Lastly,
we didn’t compare the effects of cigar smoking with
those of cigarette smoking. However, the purpose of this
study was not to suggest that cigar smoking is either
safer or more harmful than cigarette smoking. This
study aimed to add to the limited evidence supporting
that cigar smoking is harmful for human lung and only a
single cigar smoking can have significant deleterious
effects on the airway function.
Conclusion
CS has immediate effects on pulmonary function, expressed
as ventilation heterogeneity due to peripheral bronchocon-
striction in young smokers with mild asthma, and central
airways dysfunction in otherwise healthy young smokers.
Even though such pathophysiological alterations have no
acute clinical expression, they may result in early manifest-
ation of COPD, while clinical status or even FEV1 and PEF
values may be normal. This hypothesis needs to be tested,
especially for asthmatic smokers.
Our results add to the limited evidence that CS is not
safe. Given the high prevalence of cigar smoking, espe-
cially amongst the youth [11], tobacco prevention policies
must become more focused on “alternative” ways of smok-
ing being promoted as more glamourous and safer, and
especially on cigar smoking.
Endnotes
1Brand of the cigar is not referred intentionally. Manu-
facturer’s description of the cigar: fermented, non-flavored
tobacco, 70 % humidity at 26 °C (80 °F).
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